Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Stellate Ganglion Block for Major Depressive Disorder: A Randomized Controlled Pilot Trial

NCT04727229 is registered in ClinicalTrials.gov with Unity Health Toronto as lead sponsor.

NCT NCT04727229
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04727229 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Stellate Ganglion Block for Major Depressive Disorder: A Randomized Controlled Pilot Trial
Lead sponsor
Unity Health Toronto
Phase
Phase 4
Overall status
Completed
Start date
September 23, 2021
Completion date
March 10, 2022
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

major depressive disorder, treatment resistant depression